Skip to main content
. 2021 Nov 3;11(11):437. doi: 10.3390/bios11110437

Figure 5.

Figure 5

ROC for (a) bladder cancer vs. PCa; (b) bladder cancer vs. non-cancerous group; and (c) prostate cancer vs. non-cancerous group using GC-TOF-MS.